Inventory and Vial Shrinkage Control: Where Product (and Money) Actually Disappears

Shrinkage is the gap between the product you bought and the product you can account for — units billed to patients, plus documented waste, plus legitimate samples. Everything in that gap is money that left the building as product without coming back as revenue. It bundles together a whole family of leaks: dead-space loss at draw-up, expiration of reconstituted or unused product, uncharged "top-offs" and comps, charting that doesn't match what was actually used, and, yes, occasionally genuine theft. The unifying feature is that almost none of it announces itself. There's no broken window, no missing register cash — just a slow divergence between what you purchased and what you billed.

Why injectables leak the most

Injectables are the worst offender precisely because the individual losses are too small to feel like losses. A few units lost to hub dead space don't feel like waste. An expired vial at the end of a slow week doesn't feel like theft. Two units comped at a follow-up don't feel like anything at all. Each event is trivial and forgettable, and the fast clinical workflow gives none of them any friction. But they happen on every vial, every day, and the accumulation across a year is a number that genuinely startles owners the first time they measure it — frequently a meaningful slice of injectable margin that simply evaporated, unrecorded, one forgettable event at a time.

Measure the gap, by product, on a cycle

You cannot manage what you've never reconciled, and most practices have never reconciled this. The discipline is straightforward: on a regular cycle, compare product purchased against product accounted for — units billed plus documented waste and samples — for each product. The persistent unexplained gap is your shrinkage, and its size tells you how big the opportunity is. The first reconciliation is usually the most valuable thing an owner does all quarter, because it converts a vague sense that "we go through a lot of product" into a specific number you can attack.

Most of it is process, which is why it's fixable

Here's the encouraging part: the majority of shrinkage in a well-meaning practice is process leakage, not theft — dead space, expiration, uncharged units, mis-charting. That's good news because process is fixable with systems and accountability in a way that bad actors are not. Low-dead-space draw-up technique cuts the hub waste. Booking clusters and tighter ordering cut expiration. A culture where every unit injected gets charted and charged cuts the silent comps. Reconciliation itself creates the accountability that closes mis-charting — and, not incidentally, the same visibility that fixes process leakage is exactly what deters the theft that does occur. You don't have to choose between assuming the best and protecting the asset; tracking does both.

What to do

• Reconcile purchased versus accounted-for product by line, on a regular cycle. The first reconciliation will tell you how big your leak is; you almost certainly don't know yet.
• Attack the process leaks: low-dead-space technique for hub waste, booking and ordering discipline for expiration, and a hard rule that every unit injected is charted and charged.
• Build accountability into the workflow so product movement is visible — which closes mis-charting and deters theft at the same time.
• Treat shrinkage control as recurring, not a one-time audit. The leak reopens the moment the attention stops.

In a business this dependent on small, expensive, easy-to-mis-record product, shrinkage isn't an exotic risk — it's the default state of any practice that doesn't actively measure and manage it. The losses don't feel like losses, which is exactly why they persist. Reconcile the gap, fix the process leaks, build the accountability, and you'll recover margin that was always yours and was leaving, unnoticed, in the most ordinary moments of the day.